Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Miravirsen dosing in chronic hepatitis C patients results in decreased micro RNA‐122 levels without affecting other micro RNA s in plasma

Open access
van der Ree, M. H., van der Meer, A. J., van Nuenen, A. C., de Bruijne, J., Ottosen, S., Janssen, H. L., Kootstra, N. A., Reesink, H. W. · 2016 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Micro RNA‐122 (miR‐122) is an important host factor for hepatitis C virus replication. Administration of miravirsen, an anti‐miR‐122 oligonucleotide, resulted in a dose dependent and prolonged decrease in HCV RNA levels in chronic hepatitis C patients. Aim: To assess the plasma level of various mi RNA s in patients dosed with miravirsen. Methods: We included 16 of 36 chronic hepatitis C patients who received five injections of either 3 mg/kg (n = 4), 5 mg/kg (n = 4), 7 mg/kg (n = 4) miravirsen or placebo (n = 4) over a 4‐week period in a double‐blind, randomised phase 2a study. Plasma levels of 179 mi RNA s were determined by qPCR and compared between patients dosed with miravirsen or placebo. Results: Median plasma miR‐122 level at baseline in patients receiving miravirsen was 3.9 × 10 3 compared to 1.3 × 10 4 copies/4 μL in placebo‐dosed patients (P = 0.68). At week 1, 4, 6 and 10/12, patients dosed with miravirsen had respectively a median 72‐fold, 174‐fold, 1109‐fold and 552‐fold lower expression of miR‐122 than at baseline (P = 0.001, as compared to patients receiving placebo). At week 4 of dosing, mi RNA‐profiling demonstrated a significant lower expression of miR‐210 and miR‐532‐5p compared to baseline (3.0 and 4.7‐fold lower respectively). However, subsequent longitudinal analysis showed no significant differences in miR‐210 and miR‐532‐5p plasma levels throughout the study period. Conclusions: We demonstrated a substantial and prolonged decrease in plasma miR‐122 levels in patients dosed with miravirsen. Plasma levels of other mi RNA s were not significantly affected by antagonising miR‐122.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13432

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
van der Ree, M. H., van der Meer, A. J., van Nuenen, A. C., de Bruijne, J., Ottosen, S., Janssen, H. L., Kootstra, N. A., & Reesink, H. W.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2015-10-26
Volume
43
Issue
1
Pages
102-113
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1911381531
Cited by
159
References
4
FWCI
6.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.